KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 34,393 | $331 | 0.00% |
| LMR Partners LLP | 25,000 | $240,750 | 0.00% |
| CITIGROUP INC | 276,918 | $2,666,721 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 582,905 | $5,613,467 | 0.00% |
| Quantbot Technologies LP | 3,200 | $30,816 | 0.00% |
| ALPS ADVISORS INC | 25,338 | $244,005 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 10,500 | $101,115 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 74,000 | $712,620 | 0.00% |
| Citadel Advisors | 928,502 | $8,941,474 | 0.00% |
| Red Tortoise LLC | 187 | $1,801 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 12,290 | $118,353 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 22,941 | $220,922 | 0.00% |
| Walleye Capital LLC | 58,378 | $562,180 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 1,353 | $13,029 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,714 | $26,135 | 0.00% |
| NORTHERN TRUST CORP | 275,218 | $2,650,350 | 0.00% |
| MARSHALL WACE, LLP | 51,524 | $496,176 | 0.00% |
| Rathbones Group PLC | 19,022 | $183,182 | 0.00% |
| MetLife Investment Management, LLC | 12,495 | $120,327 | 0.00% |
| Renaissance Technologies | 69,100 | $665 | 0.00% |
External links
This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q3 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.